All In Biotech

Free tool

FAERS Monitor: Ritalin La

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021284 or its brand name (Ritalin La, Methylphenidate Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

15,239

Serious

10,224

67% of reports

Hospitalization

3,632

Death reported

1,114

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,483
  • off label use912
  • fatigue776
  • nausea727
  • anxiety722
  • toxicity to various agents687
  • headache673
  • depression576
  • somnolence503
  • insomnia500
  • condition aggravated497
  • dizziness483
  • vomiting459
  • product substitution issue433
  • drug abuse415

Reports by year received

View as table
YearReports
200410
200526
200612
20076
20085
200919
2010165
2011233
2012302
2013425
2014423
2015749
20161,521
20171,106
20181,030
20191,055
2020914
2021868
20221,089
20231,340
20241,368
20251,416
20261,157

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,038,920 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
product substitution issueSignal43310.59.53,674
drug abuseSignal4156.96.32,090
toxicity to various agentsSignal6875.65.22,629
anxietySignal7223.53.31,306
depressionSignal5763.53.21,035
somnolenceSignal5033.53.2881
insomniaSignal5002.62.4493
condition aggravatedSignal4972.32.1352
drug ineffective1,4831.61.5311
headache6731.51.4108
off label use9121.41.4126
fatigue7761.41.382
vomiting4591.31.242
dizziness4831.31.242
nausea7271.31.242

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.